Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study-Reference-Cited by-同舟云学术

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

Published:2009-08 Issue:8 Volume:10 Page:794-800
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Faivre Sandrine,Raymond Eric,Boucher Eveline,Douillard Jean,Lim Ho Y,Kim Jun S,Zappa Magaly,Lanzalone Silvana,Lin Xun,DePrimo Samuel,Harmon Charles,Ruiz-Garcia Ana,Lechuga Maria J,Cheng Ann Lii

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

3. International trends and patterns of primary liver cancer;McGlynn;Int J Cancer,2001

4. Steatosis and hepatocellular carcinoma risk;Smedile;Eur Rev Med Pharmacol Sci,2005

5. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report;Torisu;Hepatol Res,2007

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapies for Hepatocellular Carcinoma Treatment;Liver Cancer - Multidisciplinary Approach;2024-09-11

2. Design, Synthesis and Evaluation of a Novel Teoptinib Derivative as an Effective Anti-hepatocellular Carcinoma Agent;Current Pharmaceutical Design;2024-08

3. Long-term survival and remarkably durable treatment response in a case of inoperable fibrolamellar carcinoma of the liver — a comprehensive analysis of an 8-year chemotherapeutic journey;Oncology in Clinical Practice;2024-05-24

4. Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery;Frontiers in Oncology;2023-12-13

5. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics;Journal of Hepatocellular Carcinoma;2023-11